4.6 Review

The mechanisms and therapeutic potential of long noncoding RNA NEAT1 in fibrosis

期刊

CLINICAL AND EXPERIMENTAL MEDICINE
卷 23, 期 7, 页码 3339-3347

出版社

SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10238-023-01191-1

关键词

Fibrosis; Long noncoding RNAs; NEAT1; Therapeutic target

向作者/读者索取更多资源

Fibrosis is a process involving excessive deposition of extracellular matrix that leads to tissue disruption and organ failure. NEAT1, a long noncoding RNA, plays a crucial role in the development of fibrosis and knockdown of NEAT1 can alleviate fibrosis.
Fibrosis is the excess deposition of extracellular matrix involved in the pathogenesis of chronic diseases and finally leads to the disruption of tissue architecture and failure of organ function. Long noncoding RNAs (lncRNAs) are a class of RNAs with lengths greater than 200 nucleotides and do not code proteins, which regulate gene expression at multiple levels. Nuclear-enriched abundant transcript 1 (NEAT1) is a long noncoding RNA that is widely expressed in mammalian cells and known as essential architectural scaffold for the formation of paraspeckles. Recently, the accumulating studies demonstrated that lncRNA NEAT1 was remarkable upregulated in the development of fibrosis in different organs, such as liver fibrosis, renal fibrosis, cardiac fibrosis, and lung fibrosis. More importantly, knockdown of NEAT1 remarkably alleviated fibrosis in vitro and in vivo. In this review, we summarized current studies of NEAT1 in fibrosis and hopefully aid in a better understanding of the mechanisms of fibrosis and the potential of NEAT1 as novel therapeutic target for fibrosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据